Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Cells ; 10(1)2021 Jan 19.
Article in English | MEDLINE | ID: covidwho-1041449

ABSTRACT

mRNA has emerged as an important biomolecule in the global call for the development of therapies during the COVID-19 pandemic. Synthetic in vitro-transcribed (IVT) mRNA can be engineered to mimic naturally occurring mRNA and can be used as a tool to target "undruggable" diseases. Recent advancement in the field of RNA therapeutics have addressed the challenges inherent to this drug molecule and this approach is now being applied to several therapeutic modalities, from cancer immunotherapy to vaccine development. In this review, we discussed the use of mRNA for stem cell generation or enhancement for the purpose of cardiovascular regeneration.


Subject(s)
Cardiovascular Diseases/therapy , Cell- and Tissue-Based Therapy , RNA, Messenger/therapeutic use , Regeneration , Humans , Stem Cells
SELECTION OF CITATIONS
SEARCH DETAIL